Home › Funds › BAKER BROS. ADVISORS LP › ABCL
BAKER BROS. ADVISORS LP position in ABCL
ABCELLERA BIOLOGICS INC · Health Care
BAKER BROS. ADVISORS LP reported holding 33,012,138 shares of ABCL (ABCELLERA BIOLOGICS INC) in its Q2 2026 13F filing — a position valued at US$259.1M, representing 1.35% of its reported portfolio and ranking #14 among its reported holdings. BAKER BROS. ADVISORS LP has disclosed ABCL holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How BAKER BROS. ADVISORS LP's ABCL position evolved
BAKER BROS. ADVISORS LP first disclosed a stake in ABCL in Q3 2023 at 20,763,323 shares (US$95.5M). The position peaked in Q2 2026 at 33,012,138 shares, worth US$259.1M. Across 12 filings, BAKER BROS. ADVISORS LP increased the stake 4 time(s), trimmed it 0 time(s) and left it unchanged 7 time(s). The most recent filing (Q2 2026) shows 33,012,138 shares valued at US$259.1M — an increase of 2,736,200 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 20.76M | $95.51M | New |
| Q4 2023 | 22.91M | $130.81M | Add |
| Q1 2024 | 27.53M | $124.69M | Add |
| Q2 2024 | 27.53M | $81.48M | Hold |
| Q3 2024 | 27.53M | $71.57M | Hold |
| Q4 2024 | 27.53M | $80.65M | Hold |
| Q1 2025 | 27.53M | $61.38M | Hold |
| Q2 2025 | 27.53M | $94.41M | Hold |
| Q3 2025 | 27.53M | $138.45M | Hold |
| Q4 2025 | 27.53M | $94.14M | Hold |
| Q1 2026 | 30.28M | $105.66M | Add |
| Q2 2026 | 33.01M | $259.15M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ABCL and 13F data
ABCL (ABCELLERA BIOLOGICS INC) is a Health Care company. 37 other funds we track also report a position in ABCL — the largest reported positions include ArrowMark Colorado Holdings LLC (US$32.2M), Guardian Partners Inc. (US$8.7M), Intellectus Partners, LLC (US$4.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ABCL
- ArrowMark Colorado Holdings LLC 4.11M sh · $32.22M · Q2 2026
- Guardian Partners Inc. 596.00K sh · $8.70M · Q3 2026
- Intellectus Partners, LLC 551.58K sh · $4.33M · Q2 2026
- SOFTBANK GROUP CORP. 345.16K sh · $2.71M · Q2 2026
More on BAKER BROS. ADVISORS LP
FAQ
How long has BAKER BROS. ADVISORS LP held ABCL?
BAKER BROS. ADVISORS LP has disclosed ABCL holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is BAKER BROS. ADVISORS LP's current position in ABCL?
As of Q2 2026, BAKER BROS. ADVISORS LP holds 33.01M shares of ABCL (ABCELLERA BIOLOGICS INC), valued at $259.15M, representing 1.35% of its reported portfolio and ranking #14.
Has BAKER BROS. ADVISORS LP been buying or selling ABCL?
In the latest 13F filing (Q2 2026), BAKER BROS. ADVISORS LP increased its position in ABCL. The position peaked in Q2 2026 at 33.01M shares.
Which other funds hold ABCL?
Other major institutional holders of ABCL include ArrowMark Colorado Holdings LLC, Guardian Partners Inc., Intellectus Partners, LLC, among 37 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.